ESLA Competitors & Alternatives
Compare Estrella Immunopharma, Inc. Common Stock with similar stocks in the same industry
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
ESLA
Main Stock$1.04
Tradestie Score
50
Market Cap
$49.67M
Analyst Upside
+1438.5%
Top Competitors
170 stocks in BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AMGN
Amgen Inc
|
$366.20
|
$160.70B | 23.8 | 68 | Compare |
|
GILD
Gilead Sciences Inc
|
$146.23
|
$137.92B | 22.2 | 65 | Compare |
|
ARGX
argenx SE American Depositary Shares
|
$850.87
|
$46.96B | 36.4 | 58 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$108.77
|
$24.57B | - | 53 | Compare |
|
BIIB
Biogen Inc. Common Stock
|
$185.45
|
$22.61B | 16.1 | 58 | Compare |
|
NBIX
Neurocrine Biosciences Inc
|
$137.86
|
$13.59B | 33.2 | 58 | Compare |
|
EXEL
Exelixis Inc
|
$42.65
|
$11.09B | 17.9 | 58 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$42.77
|
$10.74B | - | 57 | Compare |
|
QGEN
QIAGEN N.V.
|
$51.71
|
$10.04B | 26.6 | 57 | Compare |
|
TECH
Bio-Techne Corp.
|
$68.67
|
$9.33B | 131.9 | 56 | Compare |
More ESLA Analysis
Data updated: Feb 04, 2026 | Industry: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) (SIC 2836)
170 stocks in this industry